Carl Ola Landgren, Md, Phd

This study tests whether combining two different immunotherapy drugs with daratumumab can delay or prevent the development of active multiple myeloma in people with high-risk early-stage disease. The trial will enroll 50 adults with smoldering multiple myeloma who haven't receive…